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Cloned embryos produced by somatic cell nuclear transfer (SCNT) display a plethora of phenotypic characteristics that make them different
from fertilized embryos, indicating defects in the process of nuclear reprogramming by the recipient ooplasm. To elucidate the extent and timing of
nuclear reprogramming, we used microarrays to analyze the transcriptome of mouse SCNT embryos during the first two cell cycles. We identified
a large number of genes mis-expressed in SCNT embryos. We found that genes involved in transcription and regulation of transcription are
prominent among affected genes, and thus may be particularly difficult to reprogram, and these likely cause a ripple effect that alters the
transcriptome of many other functions, including oxidative phosphorylation, transport across membrane, and mRNA transport and processing.
Interestingly, we also uncovered widespread alterations in the maternal (i.e., non-transcribed) mRNA population of SCNT embryos. We conclude
that gene expression in early SCNT embryos is grossly abnormal, and that this is at least in part the result of incomplete reprogramming of
transcription factor genes.
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Cloning by somatic cell nuclear transfer (SCNT) is a
remarkable process that relies on the oocyte's ability to act
upon the somatic nucleus and to transform it into a nucleus
compatible with long-term embryonic development. This
process of nuclear “reprogramming” is particularly remarkable
considering the dramatic differences between somatic and early
embryonic cells. These include fundamentally different cellAbbreviations: SCNT, somatic cell nuclear transfer; EGA, embryonic
genome activation.
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doi:10.1016/j.ydbio.2006.12.015cycles and cell cycle regulation (e.g., cleavage without growth),
strikingly different gene expression profiles (Latham et al.,
1991) revealed by two-dimensional gel electrophoresis, diver-
ging modes of carbohydrate metabolism and energy production,
a different array of amino acid transporters, glucose transporters,
and ion transporters (Aghayan et al., 1992; Baltz et al., 1991a,b,
1993; Carayannopoulos et al., 2000, 2004; Chi et al., 2000;
Hogan et al., 1991; Leppens-Luisier et al., 2001; Moley et al.,
1998; Morita et al., 1994; Pantaleon and Kaye, 1998; Pantaleon
et al., 2001; Van Winkle, 2001), different mechanisms of
osmoregulation and pH regulation (Baltz et al., 1991a,b, 1993;
Edwards et al., 1998a,b; Zhao and Baltz, 1996; Zhao et al.,
1995), and dramatic differences in mitochondrial ultrastructure
and activity (Hillman and Tasca, 1969; Matsumoto et al., 1998;
Shepard et al., 1998, 2000; Sathananthan and Trounson, 2000).
Over the course of the 50 years during which SCNT studies
have been performed, first in amphibians (King and Briggs,
76 R. Vassena et al. / Developmental Biology 304 (2007) 75–891955) and more recently in mammals (for review see Latham
KE, 2004 and references therein; Campbell et al., 2005), it has
become clear that the rate of success (i.e., development to term)
is quite low (1–5%). Although incomplete nuclear reprogram-
ming is often put forth as an explanation for this poor success,
the nature of such a deficiency has never been defined.
The cell type-specific expression of transcription factors (both
activators and repressors) likely results in a distinct global pattern
of gene expression that provides a molecular signature that
defines the differentiated state of a somatic cell. The expression of
these transcription regulators, a priori, must be stable in order to
maintain a stable state of differentiation, and indeed such seems to
be the case (e.g., Hox genes in Drosophila). Thus, genes
encoding transcription factors may be among the most difficult
genes for the oocyte to reprogram during cloning. Failure to
reprogram even a small number of key transcription factor genes
could readily lead to a “ripple effect” resulting in aberrant
expression of entire networks of downstream target genes.
To determine the degree to which inefficient reprogramming
of transcription factor genes may underlie poor cloning success,
to examine clones for disruption in the expression of other
genes, and to identify specific biological processes that are
likely disrupted as a consequence, we analyzed the transcrip-
tome of clones immediately following SCNT using microarrays.
In contrast to previous studies that focused on surviving clones
of advanced development (Humpherys et al., 2002; Smith et al.,
2005), we focused on the first two cell cycles, because these
stages encompass the earliest interactions between ooplasm and
donor nuclei, and because aberrant gene regulation at these
early stages can have profound consequences for long-term
development. Our goal was therefore to determine to what
degree SCNT embryos at these early stages resemble normal
embryos of high developmental potential, and to what degree
the somatic cell program might remain expressed.
We find that, although the transcript profiles of SCNT and
fertilized embryos are quite similar at the one-cell stage,
aberrant gene transcription is nevertheless evident even at this
early stage, along with apparent disruptions in the regulation of
maternally encoded (i.e., oocyte-accumulated) mRNAs. During
the two-cell stage, as transcriptional activation ensues, the
number of aberrantly transcribed genes in SCNT embryos
increases by nearly two orders of magnitude to nearly 1000
genes, indicating a substantial continued expression of the
somatic cell program. As predicted, the aberrantly expressed
mRNAs include many involved in transcription, and also many
involved in mRNA processing, oxidative phosphorylation,
metabolism, protein biosynthesis, protein degradation, protein
modification, and transmembrane solute transport.
Materials and methods
Preparation and collection of mouse embryos
Ovulated eggs were obtained from adult (B6D2)F1 females 8–12 weeks of
age by superovulation as described (Chung et al., 2002; Gao et al., 2003, 2004b).
Adherent cumulus cells were removed by hyaluronidase treatment and the eggs
were cultured in CZB medium supplemented with glucose (Chung et al., 2002).
SCNTwas performed as described (Chung et al., 2002; Gao et al., 2003, 2004b).At the end of the procedure, cloned constructs were activated by 5.5 h of culture
in Ca2+-free CZB medium supplemented with 10 mM Sr2+ and 5 μg/ml
cytochalasin B (Chung et al., 2002). Cloned constructs were cultured in minimal
essential medium alpha formulation (MEMα) medium as described (Gao et al.,
2004b) with or without α-amanitin (24 μg/ml). For SCNT, adherent adult
cumulus cells (presumably G1 phase) from ovulated oocytes were employed as
nuclear donors. Diploid parthenogenetically activated embryos were obtained
using the same activation protocol of clones. The parthenotes were obtained
from the same pools of oocytes used to make cloned embryos and were activated
at the same time. Parthenogenetic embryos resemble normal fertilized embryos
with respect to culture requirements, but have the added advantage that they are
activated and develop in close temporal synchrony with the activated cloned
embryos. Embryos fertilized in vivo (henceforth referred to as fertilized) were
obtained by mating (B6D2)F1 mice after injection of females 8–12 weeks of age
with Pregnant Mare Serum Gonadotropin (PMSG) and human Chorionic
Gonadotrophin (hCG), as described (Chung et al., 2002; Gao et al., 2003,
2004b). Cloned, parthenogenetic, and fertilized embryos were cultured at 37 °C
in an atmosphere of 5% CO2 in air.
RNA extraction, labeling, and hybridization
For each experimental/treatment group, four pools of 20 embryos were
collected and transferred to 20 μl of extraction buffer (Picopure, Arcturus). The
tube was incubated at 42 °C for 30 min and then stored at −70 °C. RNA
extraction was performed with the Picopure RNA extraction kit according to the
manufacturer's instructions for small sample preparation. For each sample, the
mRNA population was reverse transcribed. The cDNAwas employed for a first
round of in vitro transcription, followed by random priming and a second round
of reverse transcription and in vitro transcription to achieve a linear
amplification (Affymetrix Small Sample Technical Bulletin, www.affymetrix.
com) with the following minor modifications: the initial volume for mRNA
annealing was raised to 5 μl, and the conditions for reverse transcription were
30 min at 42 °C followed by 30 min at 45 °C to increase the reaction efficiency
in GC rich regions of mRNA. The final yield of biotinylated cRNAwas 28.5 to
83.4 μg for one-cell stage embryos and 26 to 88.5 μg for two-cell stage embryos;
20 μg of cRNA per replicate was fragmented and 10 μg hybridized to
Affymetrix MOE 430 2.0 Gene Chips in the Penn Microarray Facility, then
washed and stained on fluidic stations, and scanned according to the
manufacturer's instructions.
Microarray data analysis
Microarray Analysis Suite 5.0 (MAS, Affymetrix) was used to quantify
microarray signals with default analysis parameters and global scaling to target a
mean equal to 150 signal units. Quality control parameters for all samples were
within ranges shown in Table 1. Tabular data for all samples are available at the
Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.gov/geo). The
MAS metric output was loaded into GeneSpring v7 (Silicon genetics) with per
chip normalization to the 50th percentile and per gene normalization to the
median. To minimize false positive signals, only genes called “Present” in at
least three out of four replicates in one embryo kind/condition were used for
further analysis with all statistical packages. The K-means hierarchical
clustering (HCL) of GeneSpring v7 was used among samples at the same
developmental stage to divide them into groups based on their expression
patterns and to produce groups with a high degree of similarity within groups
and low degree of similarity between groups. The outputs for these analyses are
shown in Figs. 1 and 2.
It is important to note that, although the Affymetrix MOE430 2.0 array
interrogates one gene with every probe set, 14.7% of the genes present on the
array are represented by more than one probe set. All analyses described were
performed using the Affymetrix probe set lists, except when noted where gene
numbers were used to avoid redundancy.
The filtered MAS metrics output was loaded into TIGR-MEV v3.0.3 (Saeed
et al., 1997). The Statistical Analysis of Microarray (SAM; Tusher et al., 2001)
algorithm was applied to identify genes with significant differences among
samples at the 1% false discovery rate (FDR).
Fold changes of expression differences between stages and conditions were
calculated following SAM analysis. The resulting lists of differentially expressed
Table 1
Quality control parameter for array hybridization in different kind of embryos and treatment
Parameter One-cell Two-cell
Fert. Fert.+a SCNT SCNT+a Parth. Fert. Fert.+a SCNT SCNT+a Parth.
Scale factor 1.4–2.9 0.6–1 1.3–1.9 1.7–2.3 0.9–1.1 0.8–1 1.3–1.76 0.7–1 1.6–2.2 1.4–1.7
Background 35.8–50.5 47.6–63.1 35.8–40.7 37.5–47.4 55.1–63.4 46.1–64.5 51.8–62.5 53.2–63.9 41–49.8 49.5–60.3
% P call 33.5–36.1 38–39 35.5–37.6 33.2–35.2 37.2–38.2 36.2–38.8 31.4–32.3 39.5–41.1 29.4–31.4 34.5–36
Actin 3/5 3.3–12.4 3.7–4.4 4.8–15 4.2–13.9 3.9–5.5 4.4–7.2 4.2–5.9 4.9–7.4 4.2–4.9 4.7–5.2
GAPDH 3/5 1.5–6.2 5.6–6.2 1.7–6.2 1.9–7.7 5.1–6.2 5.6–7.2 4.2–6.1 4.2–6.8 4–6.2 4.7–6.6
a=α-amanitin in culture medium; Fert.= fertilized embryos; SCNT=somatic cell nuclear transfer embryos; Parth.=parthenogenetic embryos.
77R. Vassena et al. / Developmental Biology 304 (2007) 75–89(≥ twofold) genes (Tables S1–S6) were imported into Expression Analysis
Systematic Explorer (EASE, version 2.0) to analyze gene ontology for over-
representation (Hosack et al., 2003). EASE is an algorithm designed to analyze a
list of candidate genes against a set population (in our case the list of genes
detected on the GeneChip) and to report a score that is the expression of the
likelihood of over-representation in the Gene Ontology (GO) annotation
categories for biological process, molecular function, or cellular component.
The EASE score was calculated for likelihood of over-representation of
annotation classes, and only GO biological processes with an EASE score lessFig. 1. K means hierarchical cluster (HCL) of one-cell samples compiled after
filtering for presence call in at least 3 of 4 replicates of at least one of the
conditions. C, cloned; C+a, cloned+α-amanitin; P, parthenotes; F, in vivo
fertilized; F+, a in vivo fertilized+α-amanitin.than 5% are shown. It is important to note that a significant EASE score does not
relate to an increased fold change or overall expression significance, but merely a
higher than expected number of transcripts falling into a GO annotation category.
The filtered list of transcripts overexpressed in clones versus fertilized and
parthenogenetic embryos, and also with α-amanitin-sensitive (i.e., reduced by α-
amanitin treatment) expression, and different in expression from parthenogenetic
embryos at the two-cell stage was further imported into Ingenuity Pathway
Analysis (IPA, www.ingenuity.com) in order to detect networks detailing
physical association or functional interaction among transcripts falling into
different GO annotation categories.
Quantitative RT-PCR analysis
Groups of 25–50 embryos were collected, and total RNA was isolated as
described above. Thirteen genes were selected for analysis at the one-cell and
two-cell stage, and their mRNAs quantified by reverse transcription followed by
real-time PCR (qRT-PCR). The corresponding ABI TaqMan gene expres-
sion IDs were: Zar1 (Mm-00558078), Yy1 (Mm-00456392_m1), Fos
(Mm00487425_m1), Cpa1 (Mm_00465942_m1), H1foo (Mm00506768_m1),
Zfp352 (Mm-02528443_s1), Por (Mm00435876_m1), Eif3s12 (Mm-
00503812_m1), Maf1 (Mm-00593524_g1), Klf4 (Mm-00516104_m1), Sra1
(Mm-00491755_m1),Uqcrb (Mm-00835346_gH),Psmc3 (Mm-00477177_m1).
Three replicates were used for each qRT-PCR reaction, and each mRNA was
analyzed 2–3 times per replicate. Minus RT and minus primers/probe reactions
served as controls. Quantification was normalized to the endogenous histone
H2A [Mm-00501974_s1, (Hisst2ah2aa10)] within the log linear phase of the
amplification curve using the comparative Ct method (ABI PRISM 7700
Sequence detection System, user bulletin 32). These mRNAs were selected to
be examined by qRT-PCR because of their apparent abundances as judged by
the micorarray hybridization signals and as representatives of specific func-
tional categories (see Results).
Experimental design
The objectives of this study were to determine the timing and extent of nuclear
reprogramming during the first two cell cycles of SCNTembryo development, and
to identify specific genes or categories of genes that could account for the
observed differences in phenotype between SCNTand fertilized embryos. Tomeet
these objectives, we adopted a microarray-based approach for transcript profiling
that has been used successfully for mouse oocytes and preimplantation embryos
(Zeng et al., 2004; Zeng and Schultz, 2005; Pan et al., 2005).
Although simple in concept, such studies are complicated by technical
aspects of SCNT embryo production and culture. First, it is difficult to obtain in
vivo fertilized embryos that are developing in close synchrony with SCNT
embryos, so that effects of asynchrony on relative mRNA abundances could
arise. To control for possible effects of asynchrony, we employed parthenoge-
netic controls, which are activated at the same time as SCNT embryos using the
same method, and from the same pools of eggs as those employed to prepare the
SCNT embryos. The use of parthenogenetic controls also accounts for possible
differences that might be related to the absence of a fertilizing sperm and
activation in response to chemical treatment rather than sperm factors. For this
reason, parthenogenetic controls provided a significant advantage over, for
example, in vitro fertilized embryos, as a control for possible asynchrony,
because they addressed additional aspects of the procedures used to produce
SCNT embryos.
Fig. 3. K means hierarchical cluster (HCL) of two-cell samples compiled after
filtering for presence call in at least 3 of 4 replicates of at least one of the
conditions. F KSOM, two-cell stage embryos cultured in KSOM medium, F
MEMa, two-cell stage embryos cultured in MEMα.
Fig. 2. K means hierarchical cluster (HCL) of two-cell samples compiled after
filtering for presence call in at least 3 of 4 replicates of at least one of the
conditions. C, cloned; C+a, cloned+α-amanitin; P, parthenotes; F, in vivo
fertilized; F+, a in vivo fertilized+α-amanitin.
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preferences when compared to normal embryos (Chung et al., 2002). No
single culture medium has yet been identified that is optimized for both SCNT
and normal embryos. In fact, many SCNT embryos arrest in media optimized
for embryo culture, and many fertilized embryos arrest in the somatic cell
culture media favored by SCNT embryos (Chung et al., 2002; Gao et al.,
2004b). Because our objective was to explore the limits and timing of
reprogramming, it was essential that the analyses be performed on embryos of
the highest developmental potential and cultured in the best media available for
each type of embryo. This would avoid comparisons between embryos that are
developmentally viable and embryos that are already developmentally arrested,
or between two kinds of embryos both of which are known a priori to be
compromised. Such comparisons would yield artifactual results that would be
unrelated to basic questions related to nuclear reprogramming and how well
clones resemble normal embryos. We therefore adopted the strategy of
employing the best available culture media for each kind of embryo, namely
MEMα for SCNT embryos and KSOM for parthenotes and fertilized embryos.
SCNT embryos develop very poorly in KSOM even to the four-cell stage,
making an analysis of SCNT embryo in this medium uninformative (Chung
et al., 2002; Gao et al., 2004b). Fertilized embryos and parthenogenetic
embryos have been cultured in MEMα. Although this medium has been found to
be superior to a number of grossly sub-optimummedia, KSOM remains superior
to MEMα for such embryos (Chung et al., 2002). Our strategy therefore allowed
us to compare embryos of all three classes under those culture conditions that
support the highest in vitro efficiency achievable beyond the first two cell cycles
and, more importantly, to display the greatest rates of development to the
blastocyst stage, the highest quality of blastocysts, and the most consistent rates
of development to term achievable. This permitted our microarray analysis to
reveal specific effects of SCNT and nuclear function without concern that such
differences were being contributed by less specific deficiencies related to simple
developmental arrest.This strategy, however, creates a secondary need to account for possible effect
of the different culture media. To resolve this issue, we applied two sets of
controls. In one control study, we undertook an independent microarray
comparison between fertilized two-cell embryos cultured in either KSOM or
MEMα, using the same developmental time point and data analysis parameters
described above (Fig. 3). This comparison between fertilized embryos cultured in
the two media yielded a set of 145 genes, the expression of which could
potentially be altered by the choice of culture medium (Table S7). This set of
media-sensitive genes was later compared to the lists of genes differentially
expressed between two-cell stage SCNT and normal embryos in order to reveal
potential effects of culture medium. We observed only 12 genes in common
between the media-sensitive list (Table S7) and the lists of genes altered in two-
cell SCNT embryos (see Tables S3–S6), indicating that the potential effect of the
culture systems on the overall microarray results is highly limited. As a second
test for possible effects of culture medium, we employed qRT-PCR analysis to
compare gene expression between SCNT, fertilized, and parthenogenetic control
embryos cultured either in KSOM or MEMα (Fig. 4). These analyses revealed
little if any variation between samples of fertilized control embryos cultured in
different media (compare FK and FM in Fig. 4). Although for some of the genes
assayed slightly greater differences were observed between parthenotes cultured
in the two media, qualitatively identical directional differences in gene expression
were seen even between SCNT and parthenotes, regardless of the media
employed. Collectively, these data indicate that the culture media employed for
maintaining the highest developmental potential among SCNT and control
embryos while in culture did not adversely affect the discovery of differences in
gene expression. This result confirms the robustness of the statistical analysis.
The final requirement for our array analysis was to be able to distinguish
between effects on maternal transcript populations and effects on transcribed
genes. To address this requirement, we included in our experimental design for
Fig. 4. Real-time PCR derived expression patterns of selected genes at the one-cell (A) and two-cell (B) stage cultured in different media with or without α-amanitin. Y
axes indicate the relative fold change to fertilized embryos cultured in KSOM (reference treatment, expression adjusted to =1.0). F=fertilized embryos; C=SCNT
embryos; P=parthenotes; A=amanitin treatment; K=KSOM culture medium; M=MEMα culture medium. Significant difference among kind of embryos and culture
media are indicated as follows: (a) p<0.1; (b) p<0.05; (c) p<0.01; (d) p<0.001.
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were cultured in the presence of α-amanitin, a potent RNA polymerase II
inhibitor. The treated embryos would thus display α-amanitin-dependent
reductions in mRNA abundance for transcribed genes.
Last, it is worth noting that our approach to identify sets of differentially
expressed genes incorporated stringent parameters for false discovery rate,
statistical significance of difference, and fold cutoff, combined with sequential
filtering of gene sets based on differential expression first between SCNT and
fertilized embryos, then between SCNT and parthenogenetic controls, and
finally distinctions based on α-amanitin sensitivity. The gene sets obtained are
therefore highly reliable, and thus capable of providing significant new insight
into how genes are differentially regulated between SCNT and control embryos,
and hence the extent and timing of nuclear reprogramming.Results
Overview of microarray results
The microarray data sets obtained in this study are available
in tabular form from the Gene Expression Omnibus Repository(www.ncbi.nlm.nih.gov/geo). Among the entire series of
samples (Figs. 1 and 2, one-cell, two-cell, α-amanitin-treated
and untreated) expression of between 13,230 and 18,500
mRNAs was detected (Table 1). This range reflects differences
in the complexity of the mRNA populations of different
stages/treatments of embryos. The quality control parameter
for all the samples was within the following ranges: scale
factor 0.6 to 1.9 (accepted range: 0.5 to 5.0), and background
35.8 to 64.5 (accepted range: 20 to 100); percent IDs detected
29.4 to 41.1; actin 3′/5′ signal ratio 3.3 to 12.4; GADPH 3′/5′
signal ratio 1.5 to 7.7 (Table 1). The quality control data are in
agreement with that reported in two other studies using the
same array platform (Zeng et al., 2004; Pan et al., 2005) as
well as within the ranges recommended by Affymetrix. All the
quality control parameters, as well as the internal and spiked
controls in place to ensure correct mRNA processing and
preparation, confirmed that the data sets obtained were of high
quality.
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hours of nuclear transfer. Published studies, however, indicate
that clones manifest unusual characteristics during these early
stages indicative of slow or incomplete reprogramming (Gao et
al., 2003, 2004b; review, Latham, 2004, 2005). No study to date
has attempted to measure the degree of similarity or difference
between SCNT and fertilized embryos. We used K-means
hierarchical clustering (HCL) to ascertain the overall simila-
rities/differences of embryos derived from the different treat-
ments (Figs. 1 and 2). At both developmental stages, replicate
samples of the same kind/condition clustered together and apart
from other embryo kinds/conditions, which indicates that SCNT
is indeed significantly different from control embryos with
respect to transcriptome composition. Additionally, this cluster-
ing pattern indicates a high degree of reproducibility and small
biological variability among samples of a given kind of embryo.
It is noteworthy that the HCL output of one-cell stage embryos
grouped embryos by kind and treatment, indicating that SCNT
embryos at this stage of development are already different from
both normal and parthenogenetic embryos (Fig. 1). Moreover,
the clustering of the α-amanitin-treated samples apart from non-
treated ones indicates that the α-amanitin effect is already
sizeable at this early stage.
Three other aspects of the data argue for an early effect of the
donor nucleus on the SCNT embryo phenotype. First, we see
that the two-cell stage samples treated with α-amanitin (both
fertilized and SCNT embryos) are distinct from the three non-α-
amanitin-treated groups, but that the α-amanitin-treated sam-
ples retain their cluster grouping by kind of embryo (i.e., SCNT
embryos remain separate from fertilized embryos). This indi-
cates that the maternal (i.e., not diminished by α-amanitin
treatment) mRNA population is regulated differently between
SCNT and fertilized embryos due to the difference in nuclear
origin, a point that will be addressed further below. Second,
one-cell parthenogenetic embryos cluster apart from both SCNT
and fertilized embryos, at a position intermediate between the
latter two groups. This indicates that even before the first
cleavage division, the cloned embryo transcriptome has diverged
even from that of parthenogenetic controls, which are activated
simultaneously from the same pool of eggs and developing in
close synchrony with SCNT embryos. Third, we observe that
the degree of difference between SCNT and fertilized embryos
increases between the one-cell and two-cell stages. If nuclear
reprogramming occurred rapidly after SCNT, then we would
not expect a large increase in the degree of difference between
SCNT, parthenogenetic, and fertilized embryos as develop-
ment proceeds. The two-cell HCL plot instead reveals an
increasing divergence between the three classes of embryos,
indicating that the donor cell nuclei exert a strong effect on
phenotype as the embryo proceeds through embryonic genome
activation (Fig. 2).
Global changes in mRNA population during the first
embryonic cell cycle
A most interesting question that arises from SCNT is how
well the donor cell genome is silenced after transfer intorecipient eggs. Two scenarios could be envisioned. In the first
one, as the one-cell embryo acquires the capacity to undertake
gene transcription (Latham et al., 1992), an array of donor cell
genes could be transcribed before the first cell division. Indeed,
the overall rate of transcription in clones might be increased due
to the original chromatin state of the donor genome.
Alternatively, because the ooplasm establishes a transcription-
ally repressive state within the early embryo (Latham et al.,
1992), the donor cell genome may become highly transcrip-
tionally repressed. Our microarray data distinguish between
these alternatives, and also provide an opportunity for
identifying aberrantly expressed genes. Moreover, they provide
new information about the fate of maternal transcripts in clones.
We found 259 mRNAs that were differentially expressed
between SCNT and fertilized embryos at the one-cell stage
using the cut-off filter of 2.0-fold or greater difference (Fig. 5,
1A+1B). This corresponds to only ∼1.6% of the detected
transcripts, indicating that the transcriptome of cloned one-cell
embryos is very close to that of controls. Of the 259
differentially expressed mRNAs, 137 were higher in SCNT
than in fertilized embryos (Fig. 5, 1A), whereas 122 were lower
(Fig. 5, 1B). When considering the transcripts that are different
and also sensitive to the α-amanitin treatment, however, the
numbers decreased to 45 and 8, respectively. Three mRNAs
(Fos, Yy1, Zfp352) were tested by qRT-PCR and all confirmed to
be elevated and α-amanitin-sensitive in SCNT embryos,
indicating aberrant transcription and mRNA accumulation
even at this early stage. As many as 80% of the differentially
expressed mRNAs (206 out of 259) were indeed not diminished
by α-amanitin treatment, and thus were likely of maternal origin.
Three well-known maternal transcripts (Zar1, H1foo, and Cpa1)
were confirmed by qRT-PCR to be present at a reduced
abundance in SCNT embryos when compared to normal
embryos (Fig. 4), providing further evidence that these maternal
mRNAs are indeed affected. It should be noted that the real-time
RT-PCR data did not reveal any effect of culture media in this
experiment for H1foo or any of these three maternal mRNAs
(Fig. 4). These observations indicate that the donor cell genome
ismarkedly silenced by the ooplasm at this point in development,
and that regulation of maternal mRNA stability, and possibly
translation, is altered in clones, with some maternal mRNAs
being stabilized and others being precociously degraded.
Relationship between genes affected at the one-cell stage and
specific biological processes
We next sought to determine whether any specific biological
processes were likely affected by the differential effects on the
maternal mRNA population. We attempted to divide the list of
differentially expressed maternal mRNAs into functional
categories. Of the 114 maternal mRNAs that were of lower
abundance in clones (Fig. 5, 1E), 59 had some annotation
information attached to them. We did not, however, find any
specific gene ontology (GO) category that included more than
four transcripts in the list.
Out of the 16 mRNAs (Fig. 5, 1H; Table S1) that were
expressed more highly in SCNT embryos as compared to both
Fig. 5. Number of genes differentially expressed in SCNT, in vivo fertilized and parthenogenetic embryos at the late one-cell stage. Those genes that displayed
α-amanitin-dependent reductions in mRNA abundance were judged to be transcribed, while those that did not were judged to be non-transcribed.
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sensitive manner, 10 were annotated. In sharp contrast to
the maternal mRNAs, these 10 mRNAs displayed a clear bias
in functional category, four encoding transcription factors
(9030612M13Rik, Dbp, Fos, Gadd45g), and one additional
mRNA (Zfp352) encoding a putative transcription factor (Liu
et al., 2003a). We tested and confirmed the differential expres-
sion of two of these transcripts by qRT-PCR (Fos and Zfp352;
Fig. 4). Among the six mRNAs that were more highly ex-
pressed in fertilized embryos as compared to either SCNT or
parthenogenetic embryos in an α-amanitin-sensitive manner
(Fig. 5, 1L; Table S2), none encoded transcription factors.
To determine whether the 16 genes examined in Fig. 5 and
Table S7, and overexpressed in SCNT embryos, reflected gene
activity of the donor nuclei, we examined a microarray data set
for cumulus cells generously shared with us by Dr. John Eppig
(The Jackson Laboratory). These cumulus cells were isolated
from cumulus–oocyte complexes (COCs) obtained from
PMSG-primed 22-day-old females. Additional samples corre-
sponded to cells isolated from the COCs of 12 day old females
and cultured for 10 days in vitro as described (O'Brien et al.,
2003). Of the 16 genes overexpressed in SCNT embryos, 13
were among those detected as being expressed in samples of
cells isolated directly from 22-day COCs, and one additional
gene was expressed in the in vitro cultured cells. One additional
gene (Zfp352) was confirmed by qRT-PCR (Fig. 4) to be ex-
pressed in cumulus cells from ovulated cumulus–oocyte com-
plexes (donors employed for SCNT). The remaining transcript
(C130047D21Rik) was not detected in the Eppig array data, andis not included among available ABI TaqMan gene expression
IDs, and so was not tested by qRT-PCR. Thus, of the 16 genes
that were transcribed and overexpressed in one-cell SCNT
embryos, at least 15 are expressed in cumulus cells. This
indicates that the array of genes overexpressed in one-cell
SCNT embryos correlates highly with the gene activity of the
donor nuclei.
Global changes in gene expression during the second
embryonic cell cycle
The overall array of different transcripts in both SCNT and
fertilized embryos increased at the two-cell stage compared to
the one-cell stage. In fertilized embryos, for example, the
percent P-call increased from an average of 34.9 to an average
of 37.5. Similarly, for SCNT embryos this value increased from
36.9 to 40.1 (Table 1, “% P call”). By contrast, for α-amanitin-
treated samples, no such increases were seen, and in fact the
overall transcriptome complexity diminished during this period.
We also observed a much larger difference between the average
number of transcripts detected in untreated and α-amanitin-
treated SCNT embryos than between untreated and α-amanitin-
treated fertilized embryos (9.9% and 5.7%, respectively), and
SCNT embryos exhibited a larger array of transcripts than
fertilized embryos (p<0.01). These results reflect the activation
of the embryonic genome, leading to a net increase in the
complexity of the transcript population, and indicate that SCNT
embryos transcribe an expanded array of genes at the two-cell
stage as compared to fertilized or parthenogenetic controls.
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transcriptomes of SCNTembryos and fertilized embryos (Fig. 6,
Tables S3–S6), and this was about an order of magnitude greater
than the difference observed at the one-cell stage. We found
2427 mRNAs differentially expressed between SCNT and
normal embryos (Fig. 6, 2A+2B). Of these, ∼67% (1633) were
overexpressed in SCNT embryos (Fig. 6, 2A), and 33% (794)
were under-expressed relative to fertilized embryos (Fig. 6, 2B).
Of the 163 mRNAs overexpressed in SCNT embryos, 1087
(67%) were α-amanitin-sensitive (Fig. 6, 2D), and hence
actively transcribed, whereas 546 (33%) were not diminished
by α-amanitin treatment (Fig. 6, 2C). Of the 794 mRNAs that
were expressed at reduced abundances in SCNT embryos (Fig.
6, 2E+2F), 452 (57%) were transcribed (Fig. 6, 2F) and 342
(43%) were not diminished byα-amanitin treatment (Fig. 6, 2E).
To determine the degree to which the large differences
between SCNT and fertilized embryos was the result of unique
properties of SCNT embryos, or instead might be due to
differences related to egg activation, absence of a fertilizing
sperm, or simple effects of developmental timing, we examined
in parthenogenetic embryos expression of mRNAs that were
differentially transcribed between SCNTand fertilized embryos.
Parthenogenetic embryos were prepared from the same pools of
oocytes as SCNT embryos, activated in synchrony, and cultured
in parallel, and also lack any fertilizing sperm contribution. The
expression of 880 (81%) of 1087 mRNAs that were tran-
scriptionally elevated in SCNTembryos relative to fertilized em-Fig. 6. Number of genes differentially expressed in SCNT, in vivo fertilized and parthe
dependent reductions in mRNA abundance were judged to be transcribed, while thobryos was also elevated relative to parthenogenetic controls
(Fig. 6, 2J and Table S4). None of these was media-sensitive. Of
the 452 transcribed mRNAs that were reduced in expression in
SCNT embryos relative to fertilized embryos, a majority (302,
67%) was likewise reduced in SCNT embryos relative to
parthenogenetic embryos (Fig. 6, 2M and Table S6). Seven of
these were among the media-sensitive list of genes (Table S7).
These results indicate that the defects in gene expression
detected in SCNT embryos are due to unique features of cloned
embryos, and not due to absence of a sperm, or an effect of the
egg activation protocol or developmental timing.
In addition to the above effects on transcribed genes, we
observed significant differences between clones and both
fertilized and parthenogenetic controls in the population of
non-transcribed, maternal mRNAs (Fig. 6, 2H and 2L, Tables
S3–S5). The vast majority of these differences was insensitive
to culture media (i.e., only 5 out of 373 appear in Table S7,
<1%).
Relationship between genes differentially transcribed at the
two-cell stage and specific biological processes
The large number of genes differentially expressed between
SCNT and control two-cell embryos raises the question as to
whether the aberrant regulation of these affected genes alters
specific biological processes in SCNT embryos, and hence can
account for some of the unusual characteristics observed fornogenetic embryos at the two-cell stage. Those genes that displayed α-amanitin-
se that did not were judged to be non-transcribed.
Table 2
EASE analysis output for genes upregulated at the two-cell stage in SCNT
embryos and sensitive to α-amanitin treatment (Fig. 6, Set 2J)
GO molecular function EASE score N. genes
Oxidoreductase activity 1.20E-05 50
Electron transporter activity 1.28E-04 18
NADH dehydrogenase activity 6.96E-05 9
Oxidoreductase activity, acting on NADH or NADPH 1.57E-04 11
Transporter activity 2.53E-03 68
Primary active transporter activity 2.05E-03 19
Carrier activity 5.37E-04 32
Ion transporter activity 2.49E-03 33
Cation transporter activity 2.52E-03 30
Monovalent inorganic cation transporter activity 5.75E-05 20
Sodium ion transporter activity 2.28E-04 8
Hydrogen ion transporter activity 1.34E-04 19
Characteristic molecular functions are listed for annotated genes with an EASE
score <0.05.
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expressed genes using three different computational approa-
ches. The first approach applied the Expression Analysis
Systematic Explorer (EASE) software (Table 2). Among the
transcripts over-expressed in SCNT embryos, EASE analysis
identified 13 Gene Ontology (GO) categories with an EASE
score <0.05 (Table 2). Oxidoreductase activity was the category
identified with the most significant level of over-representation,
and the transporter activity category presented the largest
number (68) of affected genes within a category. According to
the EASE analysis of the 302 mRNAs that were reduced in
expression in SCNT embryos relative to control embryos, thereFig. 7. GO functional annotation of α-amanitin sensitive transcripts upregulated in S
Numbers beside each category indicate the number of mRNAs in that category.was only one GO category (nucleic acid binding) significantly
over-represented (EASE score, 0.00295, n=155 genes).
EASE analysis is limited by the degree and accuracy of
annotations within category. Moreover it relies solely on
numerical relationships between gene lists, it does not account
for magnitudes of changes of individual genes, and cannot
account for differences in arrays of genes within categories.
Hence, although a positive result with EASE analysis provides
clear evidence that a specific process is affected, a negative
result does not exclude other biologically relevant differences.
Accordingly, we evaluated the lists of differentially expressed
mRNAs using a second approach to understand what processes
may be operating during early embryogenesis and altered by
SCNT. The transcripts in each list of differentially expressed
mRNAs were assigned to functional categories and then the
categories with the higher number of entries analyzed,
regardless of their relative over-representation (EASE) value
(Fig. 7). We also took into account the array of genes within
each category.
Of the 466 transcripts that have a GO annotation assigned to
them, the most abundant category represented was that of
transcription factors (TF) and transcriptional regulators (54
transcripts). The 54 TF mRNAs overexpressed in SCNT
embryos were elevated by ratios ranging from 2- to 12.7-fold
(Table S8). We tested and confirmed by qRT-PCR analysis the
increased expression of Klf4, Maf1, and Sra1 mRNAs (Figs. 4
and 8). The next largest categories encompassed transcripts
involved in transport across membranes (39 transcripts) and by
transcripts involved in the oxidative phosphorylation pathway
(24 transcripts), thus confirming the results of the EASECNT compared to fertilized and parthenogenetic embryos at the two-cell stage.
Fig. 9. Ingenuity pathway analysis output example of an interaction network
between transcription factors (light blue) and other upregulated genes in SCNT
two-cell embryos.
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confirmed increased expression of Uqcrb and Por (electron
transport), Psmc3 (transport), and Eif3e12 (protein biosynth-
esis; Figs. 4 and 8). It is noteworthy that the 24 transcribed and
overexpressed members of the oxidative phosphorylation
category are all encoded by nuclear genes and are distributed
among all of the OXPHOS protein complexes. Additional
categories upregulated in SCNT embryos were those of
proteolysis, peptidolysis, protein phosphorylation, and depho-
sphorylation, and protein folding.
Among the 302 α-amanitin-sensitive mRNAs that were
reduced in expression in SCNT embryos (Fig. 6, 2M) relative to
control embryos, 169 were annotated. Interestingly, the trans-
cription factor category was once again the largest category
(n=35), indicating further deficiencies in transcription regula-
tion in SCNTembryos. This category was followed by transport
across membrane (n=18), and by proteolysis (n=8) and protein
biosynthesis (n=7).
As described above, the TF category was the largest category
of affected genes identified by our manual assignment of genes
to functional categories. The combinatorial nature of interac-
tions among transcription factors raises the potential that
perturbations in TF expression could have a far-reaching effect
on the overall process of nuclear reprogramming. We therefore
used Ingenuity Pathway Analysis (IPA) to determine networks
of genes that may interact with the transcription factors whose
expression was perturbed in SCNT embryos. IPA identified 15
networks linking the affected TFs either directly or indirectly to
other affected target genes, or indicating direct interaction
between different TFs within the affected list. In the list of 54
TFs (Table S8), 42 had scientific literature and annotation
available, while 12 lacked information on interaction with otherFig. 8. Comparison between expected fold change based on microarray analysis
(black bars) and observed fold change by real-time PCR (white bars) for selected
genes in SCNT embryos at the one-cell (A) and two-cell (B) stage.transcripts. Thirty-three of the 42 annotated TFs (79%) were
identified by IPA as interacting with other TFs (31, 74%) and/or
other genes in the list of upregulated transcripts (16, 38%). A
representative example of such networks is presented in Fig. 9.
Discussion
The data presented here provide for the first time in any
species a detailed insight into the extent and timing of nuclear
reprogramming during the first two cell cycles of development,
reveal substantial disregulation of both transcription and
maternal mRNA handling, and identify specific cellular pro-
cesses that are affected by these defects. With respect to the
extent of nuclear reprogramming, our data reveal that, although
transcription in the donor nucleus appears to be greatly
extinguished by the late one-cell, the donor cell genome
nevertheless manifests itself via transcription and accumulation
of a small array of transcripts. During the second cell cycle,
when the rate of embryonic gene transcription normally
increases, the donor cell genome directs the aberrant expression
of over 1000 different transcripts (880 also elevated relative to
parthenotes), and deficient transcription of many other genes.
These results are consistent with the previously reported
dramatic differences in SCNT embryo phenotype as compared
to fertilized or parthenogenetic control embryos (Gao et al.,
2003, 2004b; Ng and Gurdon, 2005). Indeed, we previously
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first cell division (Chung et al., 2002), and this early effect of the
donor cell genome is evident in the microarray data as well.
Superimposed on this deficiency in transcriptional repro-
gramming is a substantial disruption in the maternal mRNA
population, with a large number of maternal mRNAs being
either precociously degraded or failing to undergo degradation.
Among the transcripts differentially expressed between SCNT
and fertilized embryos at the two-cell stage, 888 (37% of the
total) were not diminished by α-amanitin treatment, and
therefore were likely of maternal origin (Fig. 6, 2C+2E); over
40% (373) of these are also affected relative to parthenotes (Fig.
6, 2H+2L). This effect on the maternal mRNA population
appears to be an intrinsic feature of clones, and not an effect of
the culture system, because only 5 of these mRNAs were
affected at the two-cell stage by choice of culture medium, and
one of these (H1foo) was also reduced in one-cell SCNT
embryos, but was not media-sensitive at that stage. Of the 373
affected maternal mRNAs, 104 were reduced in SCNT embryos
and thus appeared to be precociously degraded. This accelerated
degradation at the two-cell stage may be of comparatively little
consequence to the embryo, because it may have little effect on
expression of proteins that are being eliminated at that stage. For
example, the H1foo mRNA encodes a protein that becomes
undetectable in embryonic nuclei at the two-cell stage in both
controls and SCNT embryos (Gao et al., 2004a). Of much
greater potential significance, we observed a large number of
maternal mRNAs that were elevated in SCNT embryos (269
mRNAs elevated in clones relative to both normal and
parthenogenetic embryos; Fig. 6, 2H). These mRNAs most
likely represent maternal transcripts that are inappropriately
stabilized in the SCNT embryo. Although it is possible that
some of these mRNAs correspond to abundant mRNAs in the
donor cell cytoplasm and are transferred along with the nucleus,
this is unlikely for several reasons. First, the donor cell is quite
small in comparison to the oocyte and much of its cytoplasm is
removed before injection. Thus, it is unlikely that mRNAs in the
cumulus donor can make a substantial contribution to the array
result. Second, we observe that many mRNAs that are
expressed in somatic cells (even at high levels) but present at
very low abundances in eggs (e.g., actin, Hprt, Pdha1, Pgk1,
Prps1, Xist) are not elevated in clones. Third, it is most unlikely
that such a large number of affected mRNAs would be abundant
enough in cumulus cells to raise the observed abundance in
clones. Fourth, we observe that only 92 mRNAs are elevated
and α-amanitin-insensitive at the one-cell stage, but 269 are
affected at the two-cell stage (Fig. 5, 1C and Fig. 6, 2H), an
unlikely pattern if the source was solely the donor cell. Last, in
favor of the explanation that these mRNAs are stabilized in
clones, we find that 159 (59%) of the 269 α-amanitin-
insensitive, affected mRNAs increase in relative abundance
between the one-cell and two-cell stage, indicating a greater
stability relative to the rest of the maternal mRNA population.
Of the remaining mRNAs, 87 (32%) do not change significantly
in abundance from the one-cell to the two-cell stage, also
indicating long-term stability. Only 23 (9%) decrease in
abundance during this period. These observations indicate thatthe majority of elevated, α-amanitin-insensitive mRNAs in
SCNT embryos are very likely maternal in origin rather than
imported with the somatic nucleus. Thus, cloned embryos do
not undergo the normal elimination of a large number of
maternal mRNAs that occur in fertilized and parthenogenetic
control embryos.
The precocious loss or stabilization of a large number of
maternal mRNAs in clones was totally unanticipated. Although
the molecular basis for this phenomenon is unknown, it is
possible that the embryonic genome coordinates maternal
mRNA degradation. Consistent with this proposal is that α-
amanitin treatment apparently stabilizes some maternal mRNAs
(Worrad and Schultz, 1997; Rambhatla et al., 1995). Replacing
an embryonic genome with a somatic cell genome, with
attendant aberrant gene regulation, could therefore lead to such
defects. This explanation seems less likely for the one-cell
stage, because only a small number of genes are aberrantly
transcribed at this stage.
Depletion of factors associated with the spindle-chromosome
complex (SCC), which is removed during the first step of
cloning, could be a contributing factor. Tetraploid embryos,
prepared identically to clones but without SCC removal, display
ameliorated effects of the somatic cell genome (Gao et al.,
2003), including a lack of aberrantly expressed somatic cell type
DNMT1 (Chung et al., 2003), reduced glucose uptake, reduced
requirement for glucose in the culture medium, reduced
expression of GLUT4, correct regulation of GLUT1 localiza-
tion to the plasma membrane, and a much greater tolerance for
embryo culture medium (Gao et al., 2003). In addition, the
presence or absence of the SCC affects the pace at which the
oocyte loses the ability to direct changes in histone H1
composition (Gao et al., 2004a). Thus, absence of the regulatory
functions of the SCC could contribute to the observed
disruption in maternal mRNA stability, particularly at the one-
cell stage.
The combined effects of aberrant transcription and mRNA
handling disrupt the array of mRNAs that direct a range of
specific cellular processes. The largest group of affected
transcripts encodes transcription and mRNA processing
factors – we observe this at both the one- and two-cell
stages – such that some transcription factor genes normally
transcribed in fertilized embryos are under-expressed in
SCNT embryos. The relative abundances of mRNAs that
regulate mRNA localization and transport were also reduced in
SCNT embryos. Thus, SCNT embryos exhibit profound
deficiencies in transcriptional reprogramming. This, coupled
with a deficiency in post-transcriptional processes, could readily
result in the observed aberrant phenotype of SCNT embryos.
As briefly discussed in the Introduction, reprogramming of
transcription factors may be a difficult step in cloning because
these proteins are responsible for establishing and maintaining
a stable differentiated state of the donor somatic cell, and thus
must themselves be programmed for stable expression. Genes
that define a cell state are often among the most stable with
respect to expression programming. In Drosophila for
example, genes involved in egg polarity, and gap, pair rule,
and segmentation genes act in a sequential manner to establish
86 R. Vassena et al. / Developmental Biology 304 (2007) 75–89a combinatorial program of expression of target transcription
regulatory genes (e.g., Hox genes), which become pro-
grammed for expression in a stable spatial pattern even after
the patterning genes cease to be expressed (Gilbert, 2000).
This involves the actions of chromatin regulatory genes (e.g.,
Polycomb) that establish a stable chromatin structure. Thus,
cloned embryos may be predisposed to overexpress genes
encoding transcription factors. This would lead to aberrant
expression of numerous other downstream target genes, thus
affecting cloned embryo phenotype. Conversely, clones should
also exhibit deficiencies in expression of TF genes associated
with the embryonic state.
The results presented here support this proposal. For
example, we observe an entire network of transcriptional
regulators and their affected downstream genes to be upregu-
lated in clones. Moreover, several of the aberrantly transcribed
transcription factor genes, either in this network or otherwise, fit
the profile of genes that establish cell state by regulating a wide
array of target genes. Excellent examples of these are Sra1,
Klf4, and Cbx4. Sra1 is expressed in all human tissues
examined and encodes an RNA component of ribonucleopro-
tein complexes that contain steroid receptor coactivator-1 and
may confer specificity on these transcriptional complexes (Lanz
et al., 1999). KLF4 (GKLF) is likewise widely expressed,
participates in epithelial cell differentiation (Jaubert et al., 2003;
Segre et al., 1999), exerts anti-proliferative, pro-differentiative
effects in many cell types (Higaki et al., 2002; Hinnebusch et
al., 2004; Chen et al., 2002a,b, 2003; Foster et al., 2005; Katz et
al., 2005; Li et al., 2005; Liu et al., 2003b, 2005; Siddique et al.,
2003; Wu and Lingrel, 2004; Yoon et al., 2005), and regulates a
wide variety of genes (Ai et al., 2004; Basu et al., 2004;
Blanchon et al., 2001; Chen et al., 2002a, 2003; Chiambaretta et
al., 2004; Higaki et al., 2002; Hinnebusch et al., 2004; Jaubert et
al., 2003; Liu et al., 2003b, 2005; Miller et al., 2001; Mao et al.,
2003; Piccinni et al., 2004; Reidling and Said, 2003; Siddique et
al., 2003; Yasuda et al., 2002; Zhang et al., 2005). KLF proteins
also interact with multiple other transcription factors, such as
FLH3 and CtBP2 (Crossley et al., 1996; Gallagher et al., 2000;
Sabath et al., 1996; Scohy et al., 2000; Turner and Crossley,
1998; Turner et al., 2003; van Vliet et al., 2000; Yang et al.,
2003). We also observed increased expression of the Cbx4
mRNA in our microarray data. The CBX4 protein, like KLF4,
affects the expression of a myriad of genes, through its role in
the formation of Polycomb bodies, effects on chromatin
structure, recruitment of various factors to these complexes,
and a combination of either activating or repressive effects (e.g.,
Kagey et al., 2003, 2005; Long et al., 2005; Satijn et al., 1997).
The ability of both KLF4 and CBX4 to recruit CtBP to
regulatory complexes suggests possible cooperative interactions
between these proteins.
Another striking category of aberrantly expressed genes
included those involved in oxidative phosphorylation. Genes
encoding components of all of the OXPHOS protein complexes
are upregulated in clones, with some mRNAs overexpressed as
a result of transcription and some elevated as a result of
maternal mRNA stabilization. This may exert an effect on
carbohydrate metabolism and energy production in clones.Indeed, we have reported previously that clones display
increased glucose uptake and a strong preference for glucose-
containing media. In this regard, it is interesting to note that one
of the genes known to affect mitochondria transcription, Tfam,
is present in the list of elevated genes in two-cell SCNT
embryos (Table S4), further supporting the concept of a “ripple
effect” of altered reprogramming of transcription factor on
downstream genes and embryonic phenotype.
Another prominent affected category encodes proteins
related to solute transport and homeostasis. We observe a
large number of overexpressed mRNAs at the two-cell stage in
this category, and also a large number of maternal mRNAs that
are aberrantly stabilized at the two-cell stage. This indicates that
the cellular mechanisms regulating ion transport, amino acid
transport, intracellular pH, and osmolarity are likely altered.
This would likely contribute to the previously reported
preference of clones for somatic cell culture media (Chung et
al., 2002), which differ a great deal from embryo culture media
with respect to ionic and amino acid composition.
With such a large number of aberrantly transcribed genes, the
question arises whether so many genes are mis-expressed under
the control of a large number or a limited number of tran-
scription regulatory mechanisms. In addition to the possible
“ripple effect” that may arise downstream of mis-regulated
transcription factor encoding genes, there exists the possibility
that factors expressed in the oocyte may contribute to aberrant
gene regulation. The two-cell stage constitutes a period of
transcriptional promiscuity during which very little histone H1
linker of any type exists, and during which the ability to regulate
gene transcription is evolving (Wiekowski et al., 1997). Given
the different chromatin structure of somatic cell nuclei as
compared to gamete genomes, these conditions establish the
possibility that ooplasmic factors may initially activate a range
of genes in the somatic nucleus that might not otherwise be
activated in the normal embryo. Such activation could have
broad-reaching effects, particularly when combined with the
downstream consequences of aberrant transcription factor gene
expression.
The observations presented here provide vital new informa-
tion for evaluating the mechanisms and limitations of nuclear
reprogramming during somatic cell nuclear transfer. These data
also provide a rich foundation for understanding the basic
biology of ooplasmic–nuclear interactions, the biology of
cloning, and specific factors that must be considered if the
process is to be improved.
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